Sign in
4

Changes in Ownership

Oric Pharmaceuticals, Inc. Filed Acc 0001695028-26-000006

Chief Financial Officer sold 77,000 shares at $13.69 ($1,053,814)

  • Chief Financial Officer acquired 77,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Piscitelli Dominic Chief Financial Officer 2026-08-26 Option exercise 10b5-1 +52,000 $4.36 $226,720 121,828 D
Piscitelli Dominic Chief Financial Officer 2026-08-26 Option exercise 10b5-1 +25,000 $6.00 $150,000 146,828 D
Piscitelli Dominic Chief Financial Officer 2026-08-26 Sale 10b5-1 −77,000 $13.69 $1,053,814 69,828 D
Derivatives
Piscitelli Dominic Chief Financial Officer 2026-08-26 Option exercise · Stock Option (right to buy) 10b5-1 −52,000 92,500 D
Piscitelli Dominic Chief Financial Officer 2026-08-26 Option exercise · Stock Option (right to buy) 10b5-1 −25,000 120,000 D
Open-market sales · 77,000 sh · avg $13.69 · $1,053,814
Loading xslF345X06/form4-08282026_080834.xml…